Submitted by Anonymous (not verified) on 20 September 2023 - 16:30
Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Stomach Neoplasms;Breast Neoplasms, Date of authorisation: 09/02/2018, Revision: 20, Status: Authorised
Source:
